Flavonoids Derived from Anemarrhenae Rhizoma Ameliorate Inflammation of Benign Prostatic Hyperplasia via Modulating COX/LOX Pathways

Scientists reported that Anemarrhenae Rhizoma flavonoids inhibited benign prostatic hyperplasia-related inflammation in vivo and in vitro by targeting arachidonic acid metabolism and interfering with cyclooxygenase (COX) and lipoxygenase (LOX) pathways.